In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Hold rating on Caribou Biosciences (CRBU – Research Report), with a ...
Link to 100 Best Movies of 1975, Ranked by Tomatometer 25 Most Popular TV Shows Right Now: What to Watch on Streaming Link to 25 Most Popular TV Shows Right Now: What to Watch on Streaming What to ...
However, analysts are now seeing a potential upside of over 100% for the stock. Evercore ISI analyst Liisa Bayko raised the price target for CRISPR Therapeutics from $60.00 to $99.00. Bayko's ...
In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Akero Therapeutics (AKRO – Research Report), with a ...
Citing the Tokyo-based firm’s earnings results on Friday, Evercore ISI analyst Liisa Bayko argued that Otsuka’s (OTCPK:OTSKY) sibeprenlimab, which rivals Vera’s (NASDAQ:VERA) atacicept in ...